Safety, tolerability, immunogenicity, and efficacy of UB-311 in participants with mild Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 2a study
Titel:
Safety, tolerability, immunogenicity, and efficacy of UB-311 in participants with mild Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 2a study
Auteur:
Yu, Hui Jing Dickson, Samuel P. Wang, Pei-Ning Chiu, Ming-Jang Huang, Chin-Chang Chang, Chiung-Chih Liu, Hope Hendrix, Suzanne B. Dodart, Jean-Cosme Verma, Ajay Wang, Chang Yi Cummings, Jeffrey